中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
28期
13-13,14
,共2页
袁佳陈%永珍%华玮%朱一川
袁佳陳%永珍%華瑋%硃一川
원가진%영진%화위%주일천
危重病%C-反应蛋白%降钙素原%急性生理及慢性健康状况评分Ⅱ
危重病%C-反應蛋白%降鈣素原%急性生理及慢性健康狀況評分Ⅱ
위중병%C-반응단백%강개소원%급성생리급만성건강상황평분Ⅱ
Critical illness%C-reactive protein(CRP)%Procalcitonin(PCT)%APACHEⅡscore
目的:比较血清C-反应蛋白(CRP)、降钙素原(PCT)和急性生理和慢性健康状况评分Ⅱ(APACHEⅡ)对危重病患者预后的预测价值。方法采用前瞻、连续观察性分析方法,99例我院急诊监护室住院的危重病患者,记录患者的入院24 h内血清CRP、PCT水平和APACHEⅡ评分,并根据观察患者30 d内是否死亡,分为死亡组和存活组,比较两组患者的血清CRP、PCT水平和APACHEⅡ评分。结果死亡组的血清CRP、PCT和APACHEⅡ评分均明显高于存活组,两组之间存在显著性差异(P<0.01)。结论血清CRP、PCT和APACHEⅡ评分均对于危重病患者的早期预后有预测价值。
目的:比較血清C-反應蛋白(CRP)、降鈣素原(PCT)和急性生理和慢性健康狀況評分Ⅱ(APACHEⅡ)對危重病患者預後的預測價值。方法採用前瞻、連續觀察性分析方法,99例我院急診鑑護室住院的危重病患者,記錄患者的入院24 h內血清CRP、PCT水平和APACHEⅡ評分,併根據觀察患者30 d內是否死亡,分為死亡組和存活組,比較兩組患者的血清CRP、PCT水平和APACHEⅡ評分。結果死亡組的血清CRP、PCT和APACHEⅡ評分均明顯高于存活組,兩組之間存在顯著性差異(P<0.01)。結論血清CRP、PCT和APACHEⅡ評分均對于危重病患者的早期預後有預測價值。
목적:비교혈청C-반응단백(CRP)、강개소원(PCT)화급성생리화만성건강상황평분Ⅱ(APACHEⅡ)대위중병환자예후적예측개치。방법채용전첨、련속관찰성분석방법,99례아원급진감호실주원적위중병환자,기록환자적입원24 h내혈청CRP、PCT수평화APACHEⅡ평분,병근거관찰환자30 d내시부사망,분위사망조화존활조,비교량조환자적혈청CRP、PCT수평화APACHEⅡ평분。결과사망조적혈청CRP、PCT화APACHEⅡ평분균명현고우존활조,량조지간존재현저성차이(P<0.01)。결론혈청CRP、PCT화APACHEⅡ평분균대우위중병환자적조기예후유예측개치。
ObjectiveTo study the value of blood serum of CRP、PCT and APACHEⅡ score in predicting the development of the critical illness patients. Methods Patients were observed continuously in this perspective study.Blood samples were drawn from 99 critially ill patients admitted to emergent intensive care unit(EICU) the first 24 hours.Recorded patients’ serum CRP, PCT levels and APACHEⅡ score.And according to the observation of patients within 30 days of death, divided into death group and survival group, compared two groups of patients serum CRP, PCT levels and APACHEⅡ score.Results The death group the serum levels of CRP, PCT and APACHEⅡ score was significantly higher than the survival group, there was significant difference between the two groups (P<0.01).Conclusion Serum CRP, PCT and APACHE II scores had predictive value for the prognosis of critically ill patients.